Table 4.

Correlation matrix for change in biomarker and physical outcomes from baseline to 6 months

	ΔIGF-1	ΔIGFBP-3	ΔAdiponectin	ΔLeptin	ΔLeptin:Adiponectin	ΔIGF-1: IGFBP-3
ΔWeight (kg)	0.098	−0.179	−03.146	0.529†	0.526†	0.316
ΔBMI (kg/m2)	0.078	−0.175	−0.142	0.517†	0.524†	0.297
ΔWC (cm)	0.228	−0.163	−0.044	0.267	0.226	0.432**
ΔBF%	0.155	0.032	0.365*	−0.252	−0.529†	0.198
ΔPA Volume (MET-hrs/wk)	0.240	−0.075	−0.155	−0.132	−0.001	0.135
ΔVO2 (mlO2/kg/min)	0.142	0.045	0.087	−0.471**	−0.275	−0.133
ΔIGF-1 (ng/mL)	1	0.170	0.340	0.173	0.150	0.246
ΔIGFBP-3 (ng/mL)		1	0.200	−0.141	−0.024	−0.787‡
ΔAdiponectin (µg/mL)			1	−0.164	−0.292	−0.022
ΔLeptin (µg/mL)				1	0.773‡	0.311
ΔLeptin:Adiponectin					1	0.198

Pearson r correlations; BMI: body mass index; PA: physical activity; WC: waist circumference; BF%: body fat %; VO₂: maximal oxygen consumption peak; IGF-1: insulin-like growth factor 1; IGFBP-3: insulin-like growth factor binding protein 3;

^*p ≤ 0.1;

^**p ≤ 0.05;

^†p ≤ 0.01;

^‡p ≤ 0.001.